TRAUMA
Melatonin does not reduce the incidence of delirium among elderly hip fracture patients
This report has been verified
by one or more authors of the
original publication.
CMAJ. 2014 Oct 7;186(14):E547-56.
452 elderly patients undergoing emergent surgical treatment of hip fracture were randomized to receive melatonin or placebo for a duration of five days after admission. The purpose of this trial was to determine the short-term effects of melatonin on the incidence, duration, and severity of delirium commonly seen in this patient population. Perioperative melatonin supplementation did not reduce the incidence of delirium, but was associated with a decrease in the proportion of patients with long-lasting episodes of delirium (>2 days) compared to placebo (14/55 vs. 23/49; p=0.02). All other secondary outcomes were similar between treatment groups.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
